Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Partial loss-of-function mutations in GINS4 lead to NK cell deficiency with neutropenia
Matilde I. Conte, … , Emily M. Mace, Jordan S. Orange
Matilde I. Conte, … , Emily M. Mace, Jordan S. Orange
Published November 8, 2022
Citation Information: JCI Insight. 2022;7(21):e154948. https://doi.org/10.1172/jci.insight.154948.
View: Text | PDF
Research Article Cell biology Immunology

Partial loss-of-function mutations in GINS4 lead to NK cell deficiency with neutropenia

  • Text
  • PDF
Abstract

Human NK cell deficiency (NKD) is a primary immunodeficiency in which the main clinically relevant immunological defect involves missing or dysfunctional NK cells. Here, we describe a familial NKD case in which 2 siblings had a substantive NKD and neutropenia in the absence of other immune system abnormalities. Exome sequencing identified compound heterozygous variants in Go-Ichi-Ni-San (GINS) complex subunit 4 (GINS4, also known as SLD5), an essential component of the human replicative helicase, which we demonstrate to have a damaging impact upon the expression and assembly of the GINS complex. Cells derived from affected individuals and a GINS4-knockdown cell line demonstrate delayed cell cycle progression, without signs of improper DNA synthesis or increased replication stress. By modeling partial GINS4 depletion in differentiating NK cells in vitro, we demonstrate the causal relationship between the genotype and the NK cell phenotype, as well as a cell-intrinsic defect in NK cell development. Thus, biallelic partial loss-of-function mutations in GINS4 define a potentially novel disease-causing gene underlying NKD with neutropenia. Together with the previously described mutations in other helicase genes causing NKD, and with the mild defects observed in other human cells, these variants underscore the importance of this pathway in NK cell biology.

Authors

Matilde I. Conte, M. Cecilia Poli, Angelo Taglialatela, Giuseppe Leuzzi, Ivan K. Chinn, Sandra A. Salinas, Emma Rey-Jurado, Nixa Olivares, Liz Veramendi-Espinoza, Alberto Ciccia, James R. Lupski, Juan Carlos Aldave Becerra, Emily M. Mace, Jordan S. Orange

×

Figure 3

V171L and Q191X destabilize the expression of GINS4 and other GINS proteins and impair GINS complex assembly.

Options: View larger image (or click on image) Download as PowerPoint
V171L and Q191X destabilize the expression of GINS4 and other GINS prote...
(A) GINS4 and GINS1 protein expression in BLCL derived from siblings and parents compared with those from 2 healthy donors (HD). Relative GINS4 protein expression of family members and 2 HDs from 3 independent experiments. (B) GINS complex 3D structure showing the position of V171L and Q191X variants. (C) GINS2 and GINS3 protein expression in BLCL derived from siblings and parents compared with 2 HD. One representative experiment of 3 independent experiments is shown (D) HEK293T cells were transiently transfected with Myc-GINS4 WT, Myc-GINS4-V171L, or Myc-GINS4 Q191X plasmids. After 48 hours, whole cellular extracts were immunoprecipitated with anti-MYC, and blots were probed for GINS1, GINS2, GINS3, and MYC. Data are representative of 3 independent experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts